Related Experiment Video
Updated: Apr 26, 2026

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
Published on: November 1, 2015
Biologics in systemic lupus erythematosus: current options and future perspectives
Md Yuzaiful Md Yusof1, Edward M Vital, Paul Emery
1NIHR Academic Clinical Fellow and Specialist Registrar in Rheumatology.
None:
Data from clinical trials highlighted the potential and pitfalls of the use of biologics to treat systemic lupus erythematosus. With improved understanding of immunopathogenesis and lessons learned from controlled trials, there is a growing optimism for personalized treatment from an increasing range of targeted therapies.
Related Concept Videos
Drug Products: Biologics, Biosimilars and Interchangeables
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Microorganisms in Medicine and Therapeutics
Biopharmaceutical Factors Influencing Drug Product Design: Overview

